RankingsPricing
  1. US-listed companies
  2. ABEONA THERAPEUTICS INC.

ABEONA THERAPEUTICS INC.ABEO

Market cap
$143.69M
P/E ratio
Back to summarized table
Income statementBalance sheetCash flow
Dec 31,
2011		Dec 31,
2012		Dec 31,
2013		Dec 31,
2014		Dec 31,
2015		Dec 31,
2016		Dec 31,
2017		Dec 31,
2018		Dec 31,
2019		Dec 31,
2020		Dec 31,
2021		Dec 31,
2022
License and other revenues242925,0001889,000837,0003-1031
Royalties-----------0
Research and development42884,000333,000511173949303429
General and administrative4---1413112021242317
Impairment of goodwill----------32-
Impairment of licensed technology-----------1
Impairment of right-of-use lease assets-----------3
Impairment of construction-in-progress------------2
Total expenses109642025296177919352
Loss from operations-7,876,000-4,316,000-3,804,000-3,131,000-18,546,000-23,881,000-27,836,000-58,166,000-77,090,000-81,420,000-89,836,000-51
Gain on settlement with licensor----------7-
PPP loan payable forgiveness income----------2-
Interest income-----------0
Interest expense----------41
Change in fair value of warrant liabilities------------11
Other income-----------0
Net loss-2,532,000-10,532,0004-26,778,000-14,526,000-21,873,000-27,319,000-56,671,000-76,282,000-84,234,000-84,936,000-40
Deemed dividends related to Series A and Series B Convertible Redeemable Preferred Stock-----------4
Net loss attributable to Common Shareholders-4,306,000-12,531,0002-29,653,000-14,526,000-------43
Basic and diluted loss per common share--0.06-15.26--------5.53
Change in unrealized gains (losses) related to available-for-sale debt securities----------10,0009,000-0
Foreign currency translation adjustments-----------26,000-0
Comprehensive loss----------84,244,000-84,953,000-44